Jupiter Life Line Hospitals share price target
|

Jupiter Life Line Hospitals Share Price Target 2025, 2026, 2030, 2040, 2050

शेयर मूल्य चेतावनी Whats ऐप
शेयर मूल्य चेतावनी टेलीग्राम में शामिल हों

It is a well-known hospital group in Western India, with major hospitals in Thane, Pune, and Indore, founded by Dr Ajay Thakker, and it started operations in 2007. The company provides many types of medical care, from basic treatment to difficult surgeries and organ transplants. It offers services in more than 30 medical areas, such as heart care, cancer treatment, brain and nerve care, and advanced transplants, using modern equipment and experienced doctors. Each hospital works as a full-service centre that can manage advanced treatments on its own.

What is Jupiter Life Line Hospitals Ltd NSE: JLHL?

Jupiter Life Line Hospitals was established in 2002, established in Mumbai, Maharashtra, and founded by Dr Ajay Pratap Thakker. It is an Indian hospital group that runs multi-speciality hospitals. It provides many healthcare services, from basic check-ups to advanced surgeries, including heart treatment, cancer care, bone and joint care, brain and nerve treatment, and organ transplants. The company runs major hospitals in Thane, Pune, and Indore, with modern facilities and experienced doctors. Its main aim is to give good quality treatment, keep patients safe, and grow its hospitals in growing Indian cities.

Jupiter Life Line Hospitals Share Price Target

Jupiter Life Line Hospitals Share Price Target 2025

Jupiter Life Line Hospitals Ltd. is a well-known hospital company in India that runs large multi-speciality hospitals under the Jupiter name. The company provides both basic medical care and advanced treatment in a safe and caring environment. Jupiter hospitals treat many health problems, from small illnesses to serious and life-threatening diseases. The company follows a patient-first approach, which means the comfort, safety, and proper treatment of patients always come first. In 2025, its share price target would be ₹1770, as per stock market analysts.

According to stock market analysts, its share price would be between ₹1266 to ₹1770 in 2025.

वर्षन्यूनतम मूल्य (Rs)अधिकतम मूल्य (Rs)
202512661770
महीनान्यूनतम मूल्य (Rs)अधिकतम मूल्य (Rs)
जनवरी14671648
फ़रवरी14101706
मार्च14031770
अप्रैल12661596
मई13801500
जून14001556
जुलाई14111560
अगस्त13461480
सितंबर14001550
अक्टूबर14731625
नवंबर14051609
दिसम्बर12941658

Jupiter Life Line Hospitals Share Price Target 2026

It was started by Dr Ajay Thakker. His goal was to build hospitals that give high-quality medical care with kindness and respect. He wanted patients to feel safe and well-informed about their treatment. Under his leadership, the hospitals follow honest and fair practices and focus on long-term growth. The management team works closely with doctors and staff to improve hospital services and patient care. In 2026, its share price target would be ₹2248, as per stock market analysts.

According to stock market analysts, its share price would be between ₹1600 to ₹2248 in 2026.

वर्षन्यूनतम मूल्य (Rs)अधिकतम मूल्य (Rs)
202616002248
महीनान्यूनतम मूल्य (Rs)अधिकतम मूल्य (Rs)
जनवरी16001784
फ़रवरी16321820
मार्च16751864
अप्रैल17111882
मई17351900
जून17551935
जुलाई17741967
अगस्त17901990
सितंबर18252025
अक्टूबर18562065
नवंबर18742125
दिसम्बर19682248

शेयर मूल्य लक्ष्य 2027

It runs major hospitals in Thane and Pune in Maharashtra, and Indore in Madhya Pradesh. These cities have large populations and a growing need for good healthcare services. Each hospital is in an easy-to-reach location, so patients can arrive quickly in emergencies. The hospitals are large and can treat many patients every day. The company helps people who earlier did not have easy access to advanced medical care. In 2027, its share price target would be ₹2731, as per stock market analysts.

According to stock market analysts, its share price would be between ₹2187 to ₹2731 in 2027.

वर्षन्यूनतम मूल्य (Rs)अधिकतम मूल्य (Rs)
202721872731

शेयर मूल्य लक्ष्य 2028

It offers treatment in more than 30 medical areas, making it a true multi-speciality hospital group. These include heart care, cancer treatment, bone and joint care, brain and nerve treatment, kidney care, stomach and digestion care, women’s health, and children’s care. Patients can see different specialist doctors in the same hospital, which makes treatment easier and faster. Doctors from different departments work together, especially for serious cases, to give better results. In 2028, its share price target would be ₹3203, as per stock market analysts.

शेयर मूल्य चेतावनी Whats ऐप
शेयर मूल्य चेतावनी टेलीग्राम में शामिल हों

According to stock market analysts, its share price would be between ₹2678 to ₹3203 in 2028.

वर्षन्यूनतम मूल्य (Rs)अधिकतम मूल्य (Rs)
202826783203

शेयर मूल्य लक्ष्य 2029

Every decision is made by thinking about the patient’s comfort, safety, and health. Doctors explain health problems and treatment options in simple words so patients can understand easily. Nurses and hospital staff are trained to be kind, helpful, and respectful. The hospital environment is clean and calm to reduce fear and stress. From the time a patient comes to the hospital until they leave, the focus is on giving caring and smooth service so patients and families feel supported. In 2029, its share price target would be ₹3661, as per stock market analysts.

According to stock market analysts, its share price would be between ₹3137 to ₹3661 in 2029.

वर्षन्यूनतम मूल्य (Rs)अधिकतम मूल्य (Rs)
202931373661

Jupiter Life Line Hospitals share price Target 2030

It follows an all-hub-no-spoke model. This means each hospital works as a full medical centre on its own. Every hospital has its own operating theatres, testing labs, intensive care units, and recovery services. Patients do not need to go to another Jupiter hospital for advanced treatment. This system saves time and allows quick care during emergencies. It also makes sure that every hospital can handle serious and difficult cases by itself, making treatment easier for patients. In 2030, its share price target would be ₹4114, as per stock market analysts.

According to stock market analysts, its share price would be between ₹3580 to ₹4114 in 2030.

वर्षन्यूनतम मूल्य (Rs)अधिकतम मूल्य (Rs)
203035804114
महीनान्यूनतम मूल्य (Rs)अधिकतम मूल्य (Rs)
जनवरी35803800
फ़रवरी36253841
मार्च36653874
अप्रैल37153890
मई37513925
जून37873955
जुलाई38003978
अगस्त38354000
सितंबर38744032
अक्टूबर38904058
नवंबर39324087
दिसम्बर39784114

शेयर मूल्य लक्ष्य 2040

It uses modern medical technology to give better care. Advanced scan machines, digital patient records, and special medical equipment help doctors find health problems early and treat them correctly. Some surgeries use robotic machines to improve accuracy and help patients recover faster. Technology is also used to closely watch patients and plan treatment better. In 2040, its share price target would be ₹6795, as per stock market analysts.

According to stock market analysts, its share price would be between ₹6307 to ₹6795 in 2040.

वर्षन्यूनतम मूल्य (Rs)अधिकतम मूल्य (Rs)
204063076795
महीनान्यूनतम मूल्य (Rs)अधिकतम मूल्य (Rs)
जनवरी63076478
फ़रवरी63216500
मार्च63456541
अप्रैल63756578
मई63906590
जून64126632
जुलाई64336658
अगस्त64586684
सितंबर64846715
अक्टूबर65156754
नवंबर65356780
दिसम्बर65876800

शेयर मूल्य लक्ष्य 2050

It mainly focuses on cities and nearby areas where the need for healthcare is growing quickly. Many of these places earlier did not have advanced hospitals. By building large multi-speciality hospitals in such areas, the company helps people get quality treatment closer to their homes. This reduces long travel for patients and helps in emergencies. The company is also growing its hospital network. In 2050, its share price target would be ₹9267, as per stock market analysts.

According to stock market analysts, its share price would be between ₹8812 to ₹9267 in 2050.

वर्षन्यूनतम मूल्य (Rs)अधिकतम मूल्य (Rs)
205088129267
महीनान्यूनतम मूल्य (Rs)अधिकतम मूल्य (Rs)
जनवरी88128950
फ़रवरी88478987
मार्च88789025
अप्रैल88909045
मई89129075
जून89359090
जुलाई89451024
अगस्त89651042
सितंबर89781057
अक्टूबर89901078
नवंबर90211090
दिसम्बर90501135

Should I buy Jupiter Life Line Hospitals stock?

वर्षन्यूनतम मूल्य (Rs)अधिकतम मूल्य (Rs)
202512661770
202616002248
202721872731
202826783203
202931373661
203035804114
204063076795
205088129267

The company is growing, has strong hospitals, and is opening new ones like the Dombivli hospital. More people in India need healthcare every year, which can help the company earn more in the future. Its stock is good for long-term investment, but in the short term, profits may not increase quickly because running hospitals costs a lot of money. So, buy this stock only if you can keep it for many years. If you want quick profits or low risk, it is better to wait or not buy it now.

Jupiter Life Line Hospitals earnings results

मार्च 2020मार्च 2021मार्च 2022मार्च 2023मार्च 2024मार्च 2025टीटीएम
बिक्री +4634867338931,0731,2621,395
व्यय +3794195806918319651,070
परिचालन लाभ8467153201242297325
OPM %18%14%21%23%23%24%23%
अन्य आय +0448222938
ब्याज26394442261124
व्याख्या26313639425774
कर से पहले लाभ33277129195258265
कर10%248%34%43%10%25%
नेट प्रॉफिट +30-25173177194199
रुपये में ईपीएस5.83-0.4510.0512.9026.9429.5130.27
लाभांश भुगतान %0%0%0%0%4%3%

कुंजी मीट्रिक

TTM PE RatioPB अनुपातलाभांश प्राप्तिसेक्टर PEसेक्टर PBसेक्टर Div Yld
46.576.820.07%36.545.770.59%  

Peers & तुलना

स्टॉकपीई अनुपातPB अनुपातलाभांश प्राप्ति
Jupiter Life Line Hospitals Ltd47.786.820.07%
Max Healthcare Institute Ltd98.1411.260.14%
Apollo Hospitals Enterprise Ltd70.479.180.18%
Fortis Healthcare Ltd84.827.160.11%

Is Jupiter Life Line Hospitals stock good to buy? (bull case & bear case)

Jupiter Life Line Hospitals share price target

बुल केस:

  • In Q2 FY2025‑26, revenue grew ~17–18% to ₹393–₹405 crore, and net profit went up ~11% to ₹57 crore.
  • In Q3 FY2025, revenue grew ~18% YoY, and net profit jumped ~30%, showing steady growth.
  • More people in India need hospital services, which supports long-term growth.
  • New hospitals in Dombivli and Pune can bring more patients and revenue.
  • Q2 net profit rose ~30% compared to Q1 FY2025‑26, showing strong growth from the previous quarter.
  • In FY2024‑25, sales grew ~18% to ₹1,261 crore, and net profit increased ~10% to ₹193 crore.
  • Higher occupancy and better hospital efficiency can improve profits over time.

भालू का मामला:

  • Net profit margins in Q2 FY2025‑26 fell slightly due to rising costs.
  • High expenses for staff, machines, and new hospitals can reduce short-term profits.
  • Competition from other hospital chains may slow growth.

निष्कर्ष

It provides basic to advanced care, including surgeries and organ transplants, in over 30 specialities. With rising healthcare demand, new hospitals, and better efficiency, the company has strong long-term growth potential. Short-term profits may be affected by high costs and competition, but the stock is suitable for long-term investors.

पूछे जाने वाले प्रश्न

Revenue: ₹1,262 crore, Net Profit: ₹194 crore.

Revenue: ₹1,262 crore, Net Profit: ₹194 crore.

Its P/E ratio is ~47 as of December 2025.

समान स्टॉक